Your browser doesn't support javascript.
loading
Glioma cells require one-carbon metabolism to survive glutamine starvation.
Tanaka, Kazuhiro; Sasayama, Takashi; Nagashima, Hiroaki; Irino, Yasuhiro; Takahashi, Masatomo; Izumi, Yoshihiro; Uno, Takiko; Satoh, Naoko; Kitta, Akane; Kyotani, Katsusuke; Fujita, Yuichi; Hashiguchi, Mitsuru; Nakai, Tomoaki; Kohta, Masaaki; Uozumi, Yoichi; Shinohara, Masakazu; Hosoda, Kohkichi; Bamba, Takeshi; Kohmura, Eiji.
Affiliation
  • Tanaka K; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. kazutana@med.kobe-u.ac.jp.
  • Sasayama T; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Nagashima H; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Irino Y; Division of Evidence-Based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.
  • Takahashi M; Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan.
  • Izumi Y; Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan.
  • Uno T; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Satoh N; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Kitta A; Department of Pathology, Kobe University Graduate School of Medicine and Kobe University Hospital, Kobe, 650-0017, Japan.
  • Kyotani K; Center for Radiology and Radiation Oncology, Kobe University Graduate School of Medicine and Kobe University Hospital, Kobe, 650-0017, Japan.
  • Fujita Y; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Hashiguchi M; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Nakai T; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Kohta M; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Uozumi Y; Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Shinohara M; The Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.
  • Hosoda K; Division of Epidemiology, Kobe University Graduate School of Medicine and Kobe University Hospital, Kobe, 650-0017, Japan.
  • Bamba T; Department of Neurosurgery, Kobe City Nishi-Kobe Medical Center, Kobe, 651-2273, Japan.
  • Kohmura E; Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan.
Acta Neuropathol Commun ; 9(1): 16, 2021 01 19.
Article in En | MEDLINE | ID: mdl-33468252
ABSTRACT
Cancer cells optimize nutrient utilization to supply energetic and biosynthetic pathways. This metabolic process also includes redox maintenance and epigenetic regulation through nucleic acid and protein methylation, which enhance tumorigenicity and clinical resistance. However, less is known about how cancer cells exhibit metabolic flexibility to sustain cell growth and survival from nutrient starvation. Here, we find that serine and glycine levels were higher in low-nutrient regions of tumors in glioblastoma multiforme (GBM) patients than they were in other regions. Metabolic and functional studies in GBM cells demonstrated that serine availability and one-carbon metabolism support glioma cell survival following glutamine deprivation. Serine synthesis was mediated through autophagy rather than glycolysis. Gene expression analysis identified upregulation of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to regulate one-carbon metabolism. In clinical samples, MTHFD2 expression was highest in the nutrient-poor areas around "pseudopalisading necrosis." Genetic suppression of MTHFD2 and autophagy inhibition caused tumor cell death and growth inhibition of glioma cells upon glutamine deprivation. These results highlight a critical role for serine-dependent one-carbon metabolism in surviving glutamine starvation and suggest new therapeutic targets for glioma cells adapting to a low-nutrient microenvironment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine / Brain Neoplasms / Glioblastoma / Multifunctional Enzymes / Glutamine / Glycine / Aminohydrolases / Methylenetetrahydrofolate Dehydrogenase (NADP) Limits: Humans Language: En Journal: Acta Neuropathol Commun Year: 2021 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine / Brain Neoplasms / Glioblastoma / Multifunctional Enzymes / Glutamine / Glycine / Aminohydrolases / Methylenetetrahydrofolate Dehydrogenase (NADP) Limits: Humans Language: En Journal: Acta Neuropathol Commun Year: 2021 Document type: Article Affiliation country: Japan